Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Change in Acquisitions & Divestments (2022 - 2025)

Historic Change in Acquisitions & Divestments for Treace Medical Concepts (TMCI) over the last 4 years, with Q3 2025 value amounting to $16.2 million.

  • Treace Medical Concepts' Change in Acquisitions & Divestments fell 5066.3% to $16.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $74.8 million, marking a year-over-year decrease of 4265.92%. This contributed to the annual value of $118.5 million for FY2024, which is 123.06% down from last year.
  • Per Treace Medical Concepts' latest filing, its Change in Acquisitions & Divestments stood at $16.2 million for Q3 2025, which was down 5066.3% from $16.7 million recorded in Q2 2025.
  • Treace Medical Concepts' 5-year Change in Acquisitions & Divestments high stood at $37.0 million for Q4 2023, and its period low was $1.7 million during Q4 2022.
  • In the last 4 years, Treace Medical Concepts' Change in Acquisitions & Divestments had a median value of $24.7 million in 2024 and averaged $24.2 million.
  • As far as peak fluctuations go, Treace Medical Concepts' Change in Acquisitions & Divestments surged by 204256.8% in 2023, and later tumbled by 5400.87% in 2025.
  • Over the past 4 years, Treace Medical Concepts' Change in Acquisitions & Divestments (Quarter) stood at $1.7 million in 2022, then surged by 2042.57% to $37.0 million in 2023, then tumbled by 32.02% to $25.2 million in 2024, then tumbled by 35.73% to $16.2 million in 2025.
  • Its last three reported values are $16.2 million in Q3 2025, $16.7 million for Q2 2025, and $16.7 million during Q1 2025.